Overview

Intranasal Oxytocin and Learning in Autism

Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to determine the safety and therapeutic potential of intranasal oxytocin in children and adolescents with autism spectrum disorder (ASD) when paired with a computer game intervention that is designed to enhance face perception skills.
Phase:
Phase 2
Details
Lead Sponsor:
Robert Schultz
Treatments:
Oxytocin